Literature DB >> 20064500

Identification of NPPA variants associated with atrial fibrillation in a Chinese GeneID population.

Xiang Ren1, Chengqi Xu, Chengxiong Zhan, Yanzong Yang, Lisong Shi, Fan Wang, Chuchu Wang, Yunlong Xia, Bo Yang, Gang Wu, Pengyun Wang, Xiuchun Li, Dan Wang, Xin Xiong, Jinqiu Liu, Ying Liu, Mugen Liu, Jingyu Liu, Xin Tu, Qing Kenneth Wang.   

Abstract

BACKGROUND: A frameshift mutation in the NPPA gene was identified in 1 family with atrial fibrillation (AF), however, further studies are needed to establish unequivocally the genetic association between NPPA and AF.
METHODS: A case control association study and mutational analysis of NPPA were performed with 384 sporadic AF patients and 844 controls from a Chinese GeneID population. Genotyping was performed using High-Resolution Melt analysis. Mutational analysis was performed using direct DNA sequencing analysis.
RESULTS: Significant allelic association was detected between single nucleotide polymorphism (SNP) rs5063 and lone AF (p=0.015, OR=1.63; adjusted p=0.003). Genotypic association was significant assuming an additive or dominant model (adjusted p=0.005 and 0.007, respectively). Six new variants were identified in NPPA, including 2 in the 5'-UTR, 2 in the 3'-UTR, and 2 missense substitutions. Variants c.413T>C, c.*48G>A and c.*133G>T were not present in 844 controls, and the others were identified in controls.
CONCLUSIONS: Variants in NPPA confer risk of lone AF in a Chinese population. Thus, in addition to being a disease-causing gene with mutations identified in familial AF cases, NPPA is a susceptibility gene for lone AF. 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20064500     DOI: 10.1016/j.cca.2009.12.019

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  33 in total

Review 1.  Emerging directions in the genetics of atrial fibrillation.

Authors:  Nathan R Tucker; Patrick T Ellinor
Journal:  Circ Res       Date:  2014-04-25       Impact factor: 17.367

Review 2.  The Role of Pharmacogenetics in Atrial Fibrillation Therapeutics: Is Personalized Therapy in Sight?

Authors:  Dawood Darbar
Journal:  J Cardiovasc Pharmacol       Date:  2016-01       Impact factor: 3.105

Review 3.  Genetics of atrial fibrillation: from families to genomes.

Authors:  Ingrid E Christophersen; Patrick T Ellinor
Journal:  J Hum Genet       Date:  2015-05-21       Impact factor: 3.172

4.  Lack of association between rs3807989 in cav1 and atrial fibrillation.

Authors:  Guocao Li; Rongfeng Zhang; Lianjun Gao; Shulong Zhang; Yingxue Dong; Xiaomeng Yin; Dong Chang; Yanzong Yang; Yunlong Xia
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

5.  Evaluation of non-synonymous NPPA single nucleotide polymorphisms in atrial fibrillation.

Authors:  Jason D Roberts; Robert W Davies; Steven A Lubitz; Isabelle L Thibodeau; Pablo B Nery; David H Birnie; Emelia J Benjamin; Robert Lemery; Patrick T Ellinor; Michael H Gollob
Journal:  Europace       Date:  2010-06-12       Impact factor: 5.214

6.  Lamin A mutation impairs interaction with nucleoporin NUP155 and disrupts nucleocytoplasmic transport in atrial fibrillation.

Authors:  Meng Han; Miao Zhao; Chen Cheng; Yuan Huang; Shengna Han; Wenjuan Li; Xin Tu; Xuan Luo; Xiaoling Yu; Yinan Liu; Qiuyun Chen; Xiang Ren; Qing Kenneth Wang; Tie Ke
Journal:  Hum Mutat       Date:  2018-12-08       Impact factor: 4.878

Review 7.  A contemporary review on the genetic basis of atrial fibrillation.

Authors:  Jason D Roberts; Michael H Gollob
Journal:  Methodist Debakey Cardiovasc J       Date:  2014 Jan-Mar

Review 8.  Genomics of Atrial Fibrillation.

Authors:  Alejandra Gutierrez; Mina K Chung
Journal:  Curr Cardiol Rep       Date:  2016-06       Impact factor: 2.931

Review 9.  Genetic mechanisms of atrial fibrillation: impact on response to treatment.

Authors:  Dawood Darbar; Dan M Roden
Journal:  Nat Rev Cardiol       Date:  2013-04-16       Impact factor: 32.419

10.  Genomic variant in CAV1 increases susceptibility to coronary artery disease and myocardial infarction.

Authors:  Shanshan Chen; Xiaojing Wang; Junhan Wang; Yuanyuan Zhao; Dan Wang; Chengcheng Tan; Jingjing Fa; Rongfeng Zhang; Fan Wang; Chaoping Xu; Yufeng Huang; Sisi Li; Dan Yin; Xin Xiong; Xiuchun Li; Qiuyun Chen; Xin Tu; Yanzong Yang; Yonglong Xia; Chengqi Xu; Qing K Wang
Journal:  Atherosclerosis       Date:  2016-01-08       Impact factor: 5.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.